Altering a certain requirement that the Prescription Drug Affordability Board, in conjunction with a certain council, draft a certain plan for setting upper payment limits for prescription drug products; altering the date by which the Board is required to submit the plan to a certain committee of the General Assembly; requiring, rather than authorizing, the Board to set upper payment limits for certain prescription drug products and altering the date by which the limits are to be set to on or after February 1, 2022; etc.